Premium
Anticholinergic/sedative drug burden predicts worse memory acquisition in older racially/ethnically diverse patients with type 2 diabetes mellitus
Author(s) -
Margolis Seth A.,
Zughaft Sears Malka,
Daiello Lori A.,
Solon Carly,
Nakhutina Luba,
Hoogendoorn Claire J.,
Gonzalez Jeffrey S.
Publication year - 2019
Publication title -
international journal of geriatric psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 129
eISSN - 1099-1166
pISSN - 0885-6230
DOI - 10.1002/gps.5173
Subject(s) - repeatable battery for the assessment of neuropsychological status , medicine , sedative , anticholinergic , gerontology , type 2 diabetes mellitus , psychiatry , neuropsychology , cognition , diabetes mellitus , psychology , clinical psychology , endocrinology
Objective Anticholinergic/sedative drug use, measured by the Drug Burden Index (DBI), is linked to cognitive impairment in older adults. Yet, studies on the DBI's association with neuropsychological functioning are lacking, especially in underserved groups at increased risk of cognitive impairment. We examined cross‐sectional relationships between total DBI (DBI T ) and an age‐adjusted analogue (Adj DBI T ) with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in diverse adults with type 2 diabetes mellitus (T2DM). Based on results of a prior study, we anticipated higher DBIs would be associated with worse memory at older ages. Methods One hundred five adults with T2DM (age = 57 ± 9 years, 65% female, 62% Black, 27% Hispanic/Latino, Hb A1c = 7.8 ± 1.8) participated. Although memory outcomes were normally distributed, DBI T values were positively skewed. Spearman correlations assessed their bivariate relationships with RBANS. Adjusting for comorbidities, polypharmacy, Hb A1c , and education, we tested the moderating effect of age on DBI‐RBANS associations at mean ±1 standard deviations of age. Results One third of the participants endorsed current sedative/anticholinergic use. Mean DBI T was 0.385, and mean Adj DBI T was 0.393 (ranges = 0.00‐4.22). Drug burden negatively correlated with RBANS Immediate Memory (DBI T r s = −0.237, P = .013; Adj DBI T r s = −0.239, P = .014) but no other indices. There was a significant DBI*Age interaction; the negative effect of drug burden on Immediate Memory was significant for ages greater than or equal to 55 years old. Conclusions Sedative/anticholinergic drug exposure was prevalent in these diverse T2DM patients. Adjusting for covariates, greater drug burden was associated with worse memory acquisition among older adults only. Prospective studies should examine these relationships over time and assess whether dementia biomarkers affect the interaction.